TRCT
GLS.WS

Tower Research Capital (TRC)’s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS.WS Stock Holding History

Tower Research Capital (TRC)’s Portfolio GLS.WS Stock Details GLS.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-107
Closed – – 6661
2023
Q1 		$0 Hold
107
– – ﹤0.01% 6764
2022
Q4 		$0 Hold
107
– – ﹤0.01% 6744
2022
Q3 		$0 Hold
107
– – ﹤0.01% 6831
2022
Q2 		$0 Hold
107
– – ﹤0.01% 6897
2022
Q1 		$0 Buy
+107
New +$25 ﹤0.01% 6963

Tower Research Capital (TRC)'s GLS.WS Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) in Q2 2023, closing a stake of 107 shares.

Tower Research Capital (TRC) first reported a position in GLS.WS in Q1 2022 and held it in 5 quarters. The position peaked at $0 in Q1 2023. 0 funds tracked by Wall St. Rank hold GLS.WS as of Q2 2023.

  • Tower Research Capital (TRC) reported no remaining Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 107 Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q2 2023.
  • Tower Research Capital (TRC) first reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $0 in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.